(Q38331885)

2 September 2017

title

Insulin-like growth factor II mRNA-binding protein 3 expression predicts unfavorable prognosis in patients with neuroblastoma (English)

1 reference

2 September 2017

Ya-Ling Lee

10

0 references

Szu-Ta Chen

Szu-Ta Chen

1

0 references

Hsiu-Hao Chang

Hsiu-Hao Chang

4

0 references

Min-Chuan Huang

Min-Chuan Huang

5

0 references

Chun-Hua Hsu

Chun-Hua Hsu

7

0 references

Hsinyu Lee

Hsinyu Lee

8

0 references

Wen-Ming Hsu

Wen-Ming Hsu

11

0 references

Hsueh-Fen Juan

Hsueh-Fen Juan

6

0 references

Yung-Ming Jeng

Yung-Ming Jeng

2

0 references

Hong-Shiee Lai

Hong-Shiee Lai

12

0 references

author name string

Cheng-Chi Chang

3

1 reference

2 September 2017

Yung-Feng Liao

9

1 reference

2 September 2017

publication date

17 October 2011

1 reference

2 September 2017

1 reference

2 September 2017

volume

102

1 reference

2 September 2017

issue

12

1 reference

2 September 2017

page(s)

2191-2198

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02100.X

2 September 2017

1 reference

Trk receptor tyrosine kinases: a bridge between cancer and neural development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02100.X

The MYCN enigma: significance of MYCN expression in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02100.X

Expression of the highly conserved RNA binding protein KOC in embryogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02100.X

Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02100.X

KOC (K Homology Domain Containing Protein Overexpressed in Cancer)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02100.X

The RNA-binding protein Vg1 RBP is required for cell migration during early neural development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02100.X

Transgenic overexpression of the oncofetal RNA binding protein KOC leads to remodeling of the exocrine pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02100.X

RNA-binding IMPs promote cell adhesion and invadopodia formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02100.X

Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02100.X

L523S, an RNA-binding protein as a potential therapeutic target for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02100.X

Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02100.X

Tissue inhibitor of metalloproteinase-3 via oncolytic herpesvirus inhibits tumor growth and vascular progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02100.X

Neuroblastoma: biological insights into a clinical enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02100.X

Retinoic acid downregulates Rae1 leading to APC(Cdh1) activation and neuroblastoma SH-SY5Y differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02100.X

The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02100.X

Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02100.X

RNA-binding protein insulin-like growth factor mRNA-binding protein 3 (IMP-3) promotes cell survival via insulin-like growth factor II signaling after ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02100.X

RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02100.X

A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02100.X

MYCN amplification remains prognostically strong 20 years after its “clinical debut”

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02100.X

10.1111/J.1349-7006.2011.02100.X

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference